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 This study was aimed to develop a fast, inexpensive, simple, and not involving 
hazardous reagent for the determination of rifampicin (RIF), isoniazid (INH), 
pyrazinamide (PZA) dan ethambutol hydrochloride (ETH) in 4FDC tablet  
based on infrared spectrophotometry in combination with chemometrics of 
partial least square (PLS) calibration. The analytical procedure involves three 
steps, namely calibration, validation and sample  assay. The multivariate  
calibration model is evaluated by determining the precision and accuracy 
parameters, as suggested by IUPAC. The results showed that the optimized 
wavenumber range for the determination of RIF was the combined 
wavenumbers of 433 – 1552 cm-1 and 1756 – 3412 cm-1, the wavenumber of 433 
– 873 cm-1 was selected for quantification of INH, 1714 – 2756 cm-1 for PZA, and 
1552 – 2970 cm-1 for ETH. The predicted residual error sum of square (PRESS) 
values of RIF, INH, PZA and ETH contents were 0.00392%, 0.011724%, 
0.007604% , and 0,003368%, respectively. The root mean square error of 
prediction (RMSEP) value s obtained for analysis of RIF, INH, PZA and ETH 
were 0.01979%, 0.03424%, 0.027575% and 0.018351%, respectively. The values 
of coefficient of determination (R2) for the relationship between actual 
values of these drugs and calculated values of these drugs using FTIR 
spectroscopy were 0.990, 0.977, 0.992 and 0.998 for RIF, INH, PZA and ETH, 
respectivelty. The developed method was succesfully applied for the 
determination of 4FDC tablet. The contents of RIF, INH, PZA and ETB in 4FDC 
tablets were in agreement with those specified in monograph of Indonesian 
Pharmacopeia. 
 
Keywords:  infrared spectrophotometry, rifampicin, isoniazid, pyrazinamide, 
ethambutol hydrochloride, partial least square. 
 
1. Introduction 
World Health Organization (WHO) reported that 
the incidency rate of tuberculosis (TB) in Indonesia was 
185 per 100.000 population with the morbidity rate was 
27 per 100.000 population every year [1]. Indonesia 
belong to the five countries with the largest number of 
tuberculosis incident cases in 2012, after India, China and 
South Africa [2]. In order to decrease the tuberculosis 
incidency, WHO and International Union against 
Tuberculosis and Lung Disease (IUATLD) have 
recommended the use of 4FDC (Fixed-Dose 
Combination) tablets for TB treatment.  4FDC contains 
150 mg rifampicin (RIF), 75 mg isoniazid (INH), 400 mg 
pyrazinamide (PZA) and 275 mg ethambutol 
hydrochloride (ETH) [3]. The chemical structure of these 
drugs were presented in Figure 1. 
Many techniques for determination of 4FDC have 
been reported in pharmaceutical formulations and 
biological samples. These methods are ultraviolet-visible 
spectrophotometric with multivariate calibration [4–7], 
polarography [8], High Performance Liquid 
Chromatography (HPLC) with UV detector [9, 10, 11], 
High Performance Thin Layer Chromatography (HPTLC) 
[12], HPLC with colorimetric detection in plasma and urin 
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[13] and by HPLC in plasma sample [14]. Infrared 
spectrophotometry in combination with multivariate 
calibration have been developed for the determination 
the contents of RIF, INH and PZA without ETH in tablet 
combination [15–17] and for determining dissolution 
testing of RIF, INH and PZA [18]. Currently, 4FDC 
monograph have used two HPLC systems with 
ultraviolet detector to quantitatively analyze the four 
constituents (RIF, INH, PZA and ETH), as listed in  
National Formulary USP30-NF25 [19] and The 
International Pharmacopoeia 4th edition [20]. However 
these methods are impractical, so that the development 
of analytical methods in one system is highly needed.  
Most of the analytical methods used for analysis 
of 4-FDC is costly and time consuming due to the sample 
preparation. Additionally, the analytical method 
indicated that the sample should be analyzed 
immediately after the sample preparation, because of 
the high unstability of certain active agent (rifampicin) 
in the solution. Hence, this method faced unsatisfactory 
to be used as a routine method for quality control of 
product. Because of this reason, Fourier Transform 
Infrared (FTIR) has already developed to be an 
alternative quantitative method for determination of 
RIF, INH, PZA and ETH in 4FDC tablet. Currently, with the 
development of computer software and multivariate 
analysis, infrared spectrophotometry is widely used to 
simultaneously analyze the mulicomponent  drugs [21]. 
This study aimed to develop a fast, inexpensive, simple, 
and not involving hazardous reagent for the 
determination of RIF, INH, PZA and ETH using infrared 
spectrophotometry in combination with multivariate 
calibration of partial least square (PLS). Study of 
chemometrics-assisted infrared spectrophotometry 
based on PLS is conducted in three phases, namely 
calibration, validation and unknown sample assay [22].   
 
2. Materials and Methods 
2.1 Material and Samples 
The reference standards of rifampicin (RIF), 
isoniazid (INH), pyrazinamide (PZA) and ethambutol 
hydrochloride (ETH) used for the calibration modelling 
were of reference standard of Indonesian 
Pharmacopoeia and obtained from the National Agency 
of Drug and Food Control, Republic of Indonesia. 
Potassium bromide with infrared spectroscopy grade 
was used for the preparation of sample powders. The 
different commercially available tablet samples 
containing RIF, INH, PZA and ETH as an active ingredient 
were obtained from National Agency of Drug and Food 
Control, distric of Medan, Indonesia. 
 
2.2  Instrumentation and Software 
The measurements of FTIR spectra of calibration 
and validation samples as well  as commercial samples 
were done using Shimadzu IR-Prestige 21 with DRS 8000 
application. All  measurements were recorded in the 
wavenumber range of 4700-400 cm-1  averaging 45 scans 
at a resolution of 4cm-1. The spectrum of each standard 
as well as sample was ratioed against a fresh 
background spectrum recorded from KBr powder.  
2.3 Preparation of calibration and validation samples 
Two set of standard mixtures containing of RIF, 
INH, PZA and ETH in the concentration range between 
0.01 and 1.0 mg were selected randomly and prepared in 
KBr to formulate powders with the total weight of 100 
mg. A set of 10 standard mixtures as calibration set 
samples and the other set of 10 standard mixtures as 
validation set of validation samples was prepared. The 
mixture composition of RIF, INH, PZA and ETH used in 
calibration and validation samples was listed in Table 1 
and Table 2, respectively. Each mixture were recorded 
using FTIR spectrophotometer in the wavenumber 
range of 4700-400cm-1 averaging 45 scans, and at a 
resolution of 4 cm-1.  
 
24  Sample preparation  
The study used two different commercially drug 
of 4FDC. Twenty tablets of each kind of samples were 
taken, weighed, and finely powdered. An accurately 150 
mg sample mixture (drugs and KBr) was prepared. Then 
the samples were scanned in wavenumber of 4700 – 
400 cm-1 averaging 45 scans at a resolution of 4 cm-1. All 
determinations were performed in three replicates for 
each kind of samples. 
 
2.5  Statistical analysis 
The spectral absorbance data were exported to 
MS excel to facilitate processing data using Minitab 
software version 16 (Minitab Corp., USA).  Some 
parameter criteria namely coefficient of determination 
(R2), root mean square error of calibration (RMSEC), 
root mean square error of prediction (RMSEP), rooot 
mean square error of cross validation (RMSECV)  and 
predicted residual sum of square (PRESS) were 
evaluated using Minitab version 16.  
 
3. Result and Discussion 
Figure 2 is FTIR spectra of the mixture of 
rifampicin (RIF), isoniazid (INH),  pyrazinamide (PZA) 
and ethambutol hydrochloride (ETH) in the calibration 
set samples (A) and in the validation set samples (B). 
The first step for analysis of RIF, INH, PZA and ETH is the 
optimization of wavenumber range capable of providing 
the highest values of coefficient of determination (R2) 
and the lowest values of errors. With the aid of 
multivariate calibration of partial least square (P LS), all 
wavenumbers in FTIR spectra can be used for 
quantitative  analysis, however, measurements from 
spectral wavelengths that are non-informative in the 
model can degrade the performance of calibration 
model [23]. Therefore, it is suggested to appropriately 
select the wavenumbers. 
Based on these criteria, finally the combined 
wavenumber region of 433 – 1552 cm-1 and 1756 – 3412 
cm-1 was used for quantitative analysis of RIF, while the 
wavenumber of 433 – 873 cm-1 was used for analysis 
INH. The wavenumber of 1714 – 2756 cm-1 is suitable for 
quantification of PZA contents, and ETH contents was 
preferred to be determined at  wavenumber of 1552 – 
2970 cm-1. Using these wavenumber regions, all 4FDC 
components have RMSEC value s close to 0 and  R2  close  
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to 1, for the relationship between actual values of RIF, 
INH, PZA,  and ETH with FTIR-partial least square 
predicted values, except PZA having R2 value of 0.987. 
These results indicated that the calibration model 
generated using those wavenumber regions are 
satisfactory. 
During the modelling using multivariate 
calibration, the over-fitting of the regression model              
can occur. Over-fitting can be understood that                      
the model generates an optimistic model in the 
calibration data set, but the model would not perform 
well    on    other   data   sets   with   similar  material [24].  
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Figure 1. Chemical structure of rifampicin (a), isoniazid (b), pyrazinamide (c) and ethambutol hydrochloride (d).  
     
 
Figure 2. Group of Infrared spectra of rifampicin, isoniazid,  pyrazinamide and ethambutol hydrochloride in calibration set 
samples (A) and validation set samples (B) 
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Figure 3. Residual plots of rifampici n (A), isoniazid (B), pyrazinamide (C), and ethambutol hydrochloride (D) from PLS 
leave one out cross validation.  
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Therefore, the calibration model should be validated. In 
this study, the validation  of calibration model was 
performed using cross validation with leave one out 
technique and external validation using external 
samples which are different from the calibration 
samples.  
Cross-validation using “leave-one out” technique 
means that the calibration samples is left out from PLS 
model, and the remaining samples are used to make PLS 
model. Furthermore, the removed sample is calculated 
using the new developed PLS model. This procedure 
was repeated; leaving each calibration sample out in 
turn. Then, the difference between the actual and 
predicted value for each sample is calculated. The sum 
of the squares of these differences is called the 
predicted residual error sum of squares (PRESS). 
Besides, root mean square errors of cross validation 
(RMSECV) and coefficient determination (R2) during 
cross validation for the relationship between actual and 
FTIR calculated values for these four drugs were also 
computed. Table 3 compiled the PRESS, RMSECV and R2 
values obtained during cross cross validation for RIF, 
INH, PZA and ETH. The residual plots of rifampicin (A), 
isoniazid (B), pyrazinamid (C) and ethambutol HCl (D) 
resulted from PLS leave one out cross validation is 
shown in Figure 3.  
The analytical results of external validation from 
validation set samples for RIF are PRESS value of 
0.00392%, RMSEP value of 0.01979% and R2 of 0.990; for 
INH, PRESS value of 0.011724%, RMSEP value of 0.03424% 
and R2 value of 0.977; for PZA, PRESS value is 
0.007604% , with RMSEP value of 0.027575% and R2 of 
0.992; and for ETH, the PRESS, RMSEP, and R2 values are 
0.003368%, 0,018351, and 0,998, respectively. The 
results assay of commercially tablet sample are RIF 
(101.26 ± 6.09%), INH (100.84 ±  4.19%), PZA (106.71 ± 
1.42%) and ETA (102.99 ±  5.19%) for  sample A, and for 
sample B, the contents obtained are 105.60 ± 2.97% 
Table 1. The composition of calibration set samples consisting of rifampicin, isoniazid,  pyrazinamide and ethambutol 
hydrochloride. 
 
No Rifampicin (mg)  Isoniazid (mg)  Pyrazinamide (mg)  Ethambutol HCl (mg) 
1 5.86 8.06 8.12 5.31  
2 2.36 4.37 7.56 3.12 
3 5.14 3.32 1.85 2.84 
4 1.44 4.96 8.09 2.38 
5 8.02 8.81  2.04 1.33 
6 2.73 5.14 4.99 0.45 
7 4.51  6.79 7.85 2.35 
8 7.40 9.46 4.25 3.40 
9 3.66 5.16 9.51  4.70 
10 3.99 2.96 4.77 9.29 
 
Table 2. The composition of validation set samples consisting of rifampicin, isoniazid,  pyrazinamide and ethambutol 
hydrochloride. 
 
No Rifampicin (mg)  Isoniazid (mg)  Pyrazinamide (mg)  Ethambutol HCl (mg) 
1 5.37 3.46 1.74 7.32 
2 6.98 5.62 0.93 5.02 
3 4.63 7.9 9.54 0.99 
4 6.25 6.87 8.58 1.27 
5 3.17 7.03 7.9 4.42 
6 2.3 5.04 4.42 1.11 
7 4.16 7.48 3.75 3.54 
8 2.68 9.82 2.58 2.38 
9 4.99 8.23 1.45 1.58 
10 1.53 2.57 7.58 9.91  
 
Table 3. The PRESS, RMSECV and R2 values obtained during cross validation for analysis of rifampicin (RIF), isoniazid (INH) , 
pyrazinamid (PZA) and ethambutol (ETH).  
 
Drugs R2 PRESS RMSECV Principle components 
RIF 0.98555 0.005962% 0.02442% 7 
INH 0.99984 0.000077% 0.00278%  8 
PZA 0.971489 0.018716%  0.04326%  3 
ETH 0.975001 0.013725%  0.03705% 5 
. 
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(RIF), 102.12 ± 2.61% (INH), 95.30 ± 3.05% (PZA) and 101.44 
± 1.76% (ETH). Based on the results, it can be concluded 
that FTIR spectrophotometry combined with 
multivariate calibration of PLS can be used as an 
alternative method to assay RIF, INH, PZA and ETH in 
4FDC tablet without separation step. 
 
4. Conclusion 
FTIR spectroscopy in combination with partial 
least square at the optimized wavenumber regions has 
been used fo the determination of rifampicin, isoniazid, 
pyrazinamide, and ethambutol hydrochloride in tablet 
combination 4FDC. The developed method has 
acceptable validation parameter and is succesfully 
applied for content assay of commercial 4FDC tablet. 
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